Literature DB >> 78757

Altered polyamine profiles in prostatic hyperplasia and in kidney tumors.

U Dunzendorfer, D H Russell.   

Abstract

Polyamine concentrations were evaluated in normal human prostatic tissue as well as hyperplastic prostate. Normal tissues had high concentrations of putrescine and spermine with intermediate spermidine concentrations, whereas there was a dramatic increase in the spermine concentration in patients with hypertrophy of the prostate. Although not highly significant, spermidine concentrations were elevated slightly in benign hyperplasia, whereas the putrescine content was decreased compared to normal tissue. Polyamine concentrations were measured also in human kidney tumors and corresponding healthy kidney tissue. The concentration of spermidine in renal carcinomas was significantly elevated when compared to histologically normal areas of the same kidney. The spermine concentration of the tumor was generally lower but not highly significant (p less than 0.01). These data suggest that polyamines are accumulated above normal levels in pathological conditions such as benign hyperplasia of the prostate and renal carcinoma. In both cases, spermidine turnover rate may be influenced by carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78757

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer.

Authors:  M van der Graaf; R G Schipper; G O Oosterhof; J A Schalken; A A Verhofstad; A Heerschap
Journal:  MAGMA       Date:  2000-07       Impact factor: 2.310

2.  Increased nuclear conjugated polyamines and transglutaminase during liver regeneration.

Authors:  M K Haddox; D H Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

3.  2-Deoxy-D-glucose inhibits the antitumor effects of alpha-difluoromethylornithine on the growth of colon cancer in vivo.

Authors:  R Saydjari; J R Upp; R W Alexander; S C Barranco; C M Townsend; J C Thompson
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

4.  Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation.

Authors:  Ling Hao; Yatao Shi; Samuel Thomas; Chad M Vezina; Sagar Bajpai; Arya Ashok; Charles J Bieberich; William A Ricke; Lingjun Li
Journal:  Int J Mass Spectrom       Date:  2018-09-22       Impact factor: 1.986

5.  Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging.

Authors:  Anya B Zhong; Isabella H Muti; Stephen J Eyles; Richard W Vachet; Kristen N Sikora; Cedric E Bobst; David Calligaris; Sylwia A Stopka; Jeffery N Agar; Chin-Lee Wu; Mari A Mino-Kenudson; Nathalie Y R Agar; David C Christiani; Igor A Kaltashov; Leo L Cheng
Journal:  Front Mol Biosci       Date:  2022-04-08

6.  Differential sensitivity of pancreatic and colon cancer to cyclosporine and alpha-difluoromethylornithine in vivo.

Authors:  R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

7.  The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Authors:  Anne R Simoneau; Eugene W Gerner; Ray Nagle; Argyrios Ziogas; Sharon Fujikawa-Brooks; Hagit Yerushalmi; Thomas E Ahlering; Ronald Lieberman; Christine E McLaren; Hoda Anton-Culver; Frank L Meyskens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

Review 8.  The Potential Role of Spermine and Its Acetylated Derivative in Human Malignancies.

Authors:  Ryan Tsz-Hei Tse; Christine Yim-Ping Wong; Peter Ka-Fung Chiu; Chi-Fai Ng
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

9.  Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.

Authors:  Meer Basharat; Maysam Jafar; Nandita M deSouza; Geoffrey S Payne
Journal:  NMR Biomed       Date:  2014-02-12       Impact factor: 4.044

10.  In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.

Authors:  Ling Hao; Tyler Greer; David Page; Yatao Shi; Chad M Vezina; Jill A Macoska; Paul C Marker; Dale E Bjorling; Wade Bushman; William A Ricke; Lingjun Li
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.